WT1 IHC Test for Ovarian & Kidney Cancer | Lahalak
WT1 protein testing aids in diagnosing serous ovarian tumors and pediatric kidney tumors, contributing to the development of a precise and targeted treatment plan.
Scientific name: Immunohistochemistry: Wilms Tumor Protein (WT1)
Immunohistochemical (IHC) testing reveals the nuclear expression of the transcription factor WT1 (Wilms' Tumor Protein 1). WT1 is normally expressed during embryonic development in the kidneys and reproductive organs. In adults, it is primarily used as a diagnostic marker for serous ovarian cancer and primary peritoneal tumors, where it is often po...
Included Services
- Detailed analysis to detect nuclear expression of the WT1 protein in tissue samples.
- Consult with a pathologist and a gynecological or pediatric oncologist to interpret the results.
- Personal support services from Halak.
Medical Service Information
Conditions & Notices
- The analysis does not require the patient to fast, as it is performed on a fixed tissue sample.
- A sufficient tissue sample of the tumor or cells (in the case of fluid samples) is necessary.
- It is often requested as part of a diagnostic package: When a tumor is diagnosed in the ovary or peritoneum, WT1 is usually requested within a diagnostic panel that includes other markers such as PAX8, p53, p16, ER/PR, and gastrointestinal markers (CK20, CDX2) for accurate differentiation.